29 related articles for article (PubMed ID: 18429258)
1. The synthesis and application of Fmoc-Lys(5-Fam) building blocks.
Tokmina-Roszyk M; Tokmina-Roszyk D; Fields GB
Biopolymers; 2013 Jul; 100(4):347-55. PubMed ID: 23444261
[TBL] [Abstract][Full Text] [Related]
2. Selective binding of matrix metalloproteases MMP-9 and MMP-12 to inhibitor-assisted thermolysin-imprinted beads.
Schauer N; Dinc M; Raabe B; Hummel T; Müller M; Sobek H; Mizaikoff B
RSC Adv; 2018 Sep; 8(57):32387-32394. PubMed ID: 35547668
[TBL] [Abstract][Full Text] [Related]
3. Sodium Bituminosulfonate Used to Treat Rosacea Modulates Generation of Inflammatory Mediators by Primary Human Neutrophils.
Schiffmann S; Gunne S; Henke M; Ulshöfer T; Steinhilber D; Sethmann A; Parnham MJ
J Inflamm Res; 2021; 14():2569-2582. PubMed ID: 34163212
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.
Sarkar P; Li Z; Ren W; Wang S; Shao S; Sun J; Ren X; Perkins NG; Guo Z; Chang CA; Song J; Xue M
J Med Chem; 2020 Jul; 63(13):6979-6990. PubMed ID: 32491863
[TBL] [Abstract][Full Text] [Related]
5. Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion.
Mori H; Yao Y; Learman BS; Kurozumi K; Ishida J; Ramakrishnan SK; Overmyer KA; Xue X; Cawthorn WP; Reid MA; Taylor M; Ning X; Shah YM; MacDougald OA
Sci Rep; 2016 Feb; 6():21520. PubMed ID: 26861754
[TBL] [Abstract][Full Text] [Related]
6. Triple-helical peptide analysis of collagenolytic protease activity.
Lauer-Fields JL; Fields GB
Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
8. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
10. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
12. Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
Troeberg L; Nagase H
Curr Protoc Protein Sci; 2004 Nov; Chapter 21():21.16.1-21.16.9. PubMed ID: 18429258
[TBL] [Abstract][Full Text] [Related]
13. Assays of matrix metalloproteinases (MMPs) activities: a review.
Lombard C; Saulnier J; Wallach J
Biochimie; 2005; 87(3-4):265-72. PubMed ID: 15781313
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
